6505--Intent to Sole Source VISN Wide Radiopharmaceutical Pluvicto Blanket purchase agreement (BPA)
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C24924Q0314
- Agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 9, has published a Special Notice indicating their intent to award a sole-source Blanket Purchase Agreement (BPA) for the manufacture and delivery of Pluvicto (lutetium Lu 177 vipivotide tetraxetan), a radioactive therapy treatment agent for prostate cancer. The BPA will have five ordering periods from December 1, 2024, to November 30, 2029, with estimated quantities ranging from 261 to 331 units per ordering period. The places of performance are listed as various VA medical centers in Tennessee and Kentucky.
The purpose of this Special Notice is to provide information about the proposed sole-source procurement and to invite interested parties to submit capability statements. Interested parties are required to submit their response, which should include their SAM UEI number, business information, and qualifications, by 10:00 AM CT on June 27, 2024. The government reserves the right to make a sole-source award to Navartis Pharmaceuticals Corporation without further competition if no responses are received. The North American Industry Classification System (NAICS) code for this requirement is 325412, Pharmaceutical Preparation Manufacturing, and the Federal Supply Class (FSC) is 6505, Drugs and Biologicals.
Notice text
INTENT TO SOLE SOURCE
This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 09, located at 1639 Medical Center Parkway, Suite 204, Murfreesboro, TN 37129 issuing an intent to award a single source blanket purchase agreement, five (5) ordering periods to Navartis Pharmaceuticals Corporation located at One Health Plaza, East Hanover, NJ 07936-1080 under FAR 13.106-1(b) and FAR 13.303 Blanket Purchase Agreements. The North American Industry Classification System (NAICS) for this requirement is 325412, Pharmaceutical Preparation Manufacturing. The Federal Supply Class (FSC) is 6505, Drugs and Biologicals. The Small Business Administration (SBA) size standard for this sector is 1,300 Employees.
VISN 9 VA Medical Center requires manufacture and delivery of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) a radioactive therapy treatment agent indicated for prostate cancer treatment.
VISN 9 VA Medical Center estimated to purchase Pluvicto in quantities listed below:
NDC#
Description
Estimated
quantities
UI
Ordering Period 1
69488-0010-61
PLUVICTO :: LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML
261
EA
Ordering Period 2
69488-0010-61
PLUVICTO :: LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML
279
EA
Ordering Period 3
69488-0010-61
PLUVICTO :: LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML
298
EA
Ordering Period 4
69488-0010-61
PLUVICTO :: LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML
317
EA
Ordering Period 5
69488-0010-61
PLUVICTO :: LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML
331
EA
See attached Statement of Work.
The Places of Performance are listed below:
James J. Quillen Veterans Affairs Medical Center
Nuclear Medicine Dept
Lamont Street & Veterans Way
Johnson City, TN 37684
Tennessee Valley Healthcare System
Nuclear Medicine Dept
1310 24th Avenue South
Nashville, TN 37212
Alvin C. York Veterans Affairs Medical Center
3400 Lebanon Pike
Murfreesboro, TN 37129
Troy Bowling Veterans Affairs Medical Center
Nuclear Medicine Dept
1101 Veterans Drive
Lexington, KY 40502
Lt. Col Luke Weathers Veterans Affairs Medical Center
Nuclear Medicine Dept
116 N Pauline Street
Memphis, TN 38105
Robley Rex Veterans Affairs Medical Center Robley Rex Veterans Affairs Medical Center
Nuclear Medicine Dept HOT LAB Nuclear Medicine Dept HOT LAB
800 Zorn Avenue 4906 Brownsboro Road
Louisville, Kentucky 40206-1499 Louisville, KY 40222
Estimated Period of Performance:
Ordering period 1: 12/01/2024-11/30/2025
Ordering period 2: 12/01/2025-11/30/2026
Ordering period 3: 12/01/2026-11/30/2027
Ordering period 4: 12/01/2027-11/30/2028
Ordering period 5: 12/01/2028-11/30/2029
Capability statement /information sought: Response to this announcement shall not to exceed 5 pages and should include the following information: (1) A tailored capability statement indicating the firm s ability to provide a product and related services; (2) The respondents SAM UEI number, organization name, address, point of contact, and size and type of business (e.g., SDVOSB/VOSB, etc,) pursuant to the applicable NAICS code; (3) Information should be provided electronically in a Microsoft Word or Adobe PDF format.
This notice of intent is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to the requirement and submit capability statement no later than 10:00 am., CT, Wednesday June 27, 2024 to: Christina.Lawrence2@va.gov. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses received to this notice is solely within the discretion of the Government. If no written response is received within the closing date of this notice, a single source blanket purchase agreement award will be made to Navartis Pharmaceuticals Corporation without any further notice.
Disclaimer and Important Notes: This notice does not obligate the Government to award an agreement or otherwise pay for the information provided in response to this notice. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. However, responses to this notice will not be considered adequate responses to a notice.
Files
| File | Type | Posted |
|---|---|---|
| 36C24924Q0314.docx | DOCX document | |
| P09-SOW VISN 9 Pluvicto.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Radiopharmaceutical Pluvicto | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Radiopharmaceuticals Base Plus Four Option Years VA San Diego Healthcare System | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside | |
| 6635--Dosimetry and Exposure Monitoring Services - VISN 1 BPA | Veterans Integrated Service Network 1 | No set-aside | |
| Sole Source Notice - Blood and Blood Products | Department of Veterans Affairs | No set-aside | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity